Clinical features of LRRK2-associated Parkinson's disease in Central Norway

Annals of Neurology

Volumn 57, Issue 5, 2005, Pages 762-765

  Aasly, Jan O ^a   Toft, Mathias ^b,c   Fernandez Mata, Ignacio ^b   Kachergus, Jennifer ^b   Hulihan, Mary ^b   White, Linda R ^c   Farrer, Matthew ^b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b MAYO CLINIC   (United States)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA; PHOSPHOTRANSFERASE; PROTEIN LEUCINE RICH REPEAT KINASE 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRADYKINESIA; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; PARKINSON DISEASE; PEDIGREE ANALYSIS; PRIORITY JOURNAL; RIGIDITY; TREMOR;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; FEMALE; HETEROZYGOTE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MUSCLE RIGIDITY; MUTATION; NORWAY; PARKINSON DISEASE; PEDIGREE; PROTEIN-SERINE-THREONINE KINASES; TREMOR;

EID: 18244394793     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20456     Document Type: Article

References (15)

1. Rocca WA, McDonnell SK, Strain KJ, et al. Familial aggregation of Parkinson's disease: the Mayo Clinic family study. Ann Neurol 2004;56:495-502.
2. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
3. Chartier-Harlin MC, Kachergus J, Roumier C, et al. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004;364:1167-1169.
4. Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004;44:601-607.
5. Paisan-Ruiz C, Jain S, Evans E, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004;44:595-600.
6. Funayama M, Hasegawa K, Kowa H, et al. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 2002;51:296-301.
7. Zimprich A, Mueller-Myhsok B, Farrer M, et al. The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval. Am J Hum Genet 2004;74:11-19.
8. Nichols WC, Pankratz N, Hernandez D, et al. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 2005;365:410-412.
9. Di Fonzo A, Rohé CF, Ferreira J. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 2005;365:412-415.
10. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-39.
11. Gilks WP, Abou-Sleiman PM, Gandhi S. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 2005;365:415-416.
12. Lohmann E, Periquet M, Bonifati V, et al. How much phenotypic variation can be attributed to parkin genotype? Ann Neurol 2003;54:176-185.
13. Quinn N, Critchley P, Marsden CD. Young onset Parkinson's disease. Mov Disord 1987;2:73-91.
14. Scott WK, Grubber JM, Conneally PM, et al. Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity. Am J Hum Genet 2000;66:922-932.
15. Wszolek ZK, Vieregge P, Uitti RJ, et al. German-Canadian family (Family A) with parkinsonism, amyotrophy, and dementia - longitudinal observations. Parkinsonism Relat Disord 1997;3:125-139.